Where does your money go?

Where does your money go?

30 October 2018

We have committed to invest £4.2 million into 13 new research projects across the UK. These include finding ways to stop the Type 1 immune attack, making the complications of diabetes less harmful, and finding the best ways to treat Type 2 diabetes.

£2.3 million will go towards five new fellowships: special awards to support talented scientists and healthcare professionals to become independent diabetes research leaders.

24 October 2018

A study funded by us has found that treating gum disease could help people with Type 2 diabetes manage their blood glucose levels, and may reduce their risk of diabetes-related complications.

Gum disease (periodontitis) affects somewhere between 50 to 90% of the population and people with diabetes have a higher risk of developing it. It sets in when levels of bacteria inside the mouth are out of balance.

31 August 2018

More than 22,000 people with diabetes currently need dialysis or a kidney transplant. Our partnership with Kidney Research UK aims to bring together expertise to understand and ultimately stop kidney disease in people with diabetes.

We've been working with Kidney Research UK and have established Clinical Studies Groups: groups of scientists, healthcare professionals and people living with either diabetes or kidney disease.

27 August 2018

New research jointly funded by Diabetes UK and the British Heart Foundation has revealed a new way to protect people with Type 2 diabetes from the harm caused by a heart-attack.

10 August 2018

The research, published in the Lancet, compared over 27,000 people with Type 1 diabetes to over 135,000 people without diabetes.

02 August 2018

Our landmark DiRECT trial has revealed further important insights into exactly how weight loss can put Type 2 diabetes into remission.

11 July 2018

Scientists at the University of Oxford are part of a global world-first study to find out if giving insulin to babies could prevent them from developing Type 1 diabetes.

Type 1 diabetes happens when the immune system mistakenly destroys insulin-producing cells in the pancreas.

26 June 2018

Our scientists show that an artificial pancreas could transform care for people with Type 2 diabetes during hospital stays.

Our scientists at the University of Cambridge have shown that an ‘artificial pancreas’ could transform the care some people with Type 2 diabetes receive during hospital stays, by improving blood glucose control without increasing the risk of hypos.

02 June 2018

An existing therapy has been shown for the first time to be a safe and effective long-term treatment for people with neonatal diabetes, in a global research study involving Diabetes UK scientists at the University of Exeter.

Neonatal diabetes is a rare form of diabetes caused by changes in specific genes. Half of all cases of neonatal diabetes are caused by a change in their KCNJ11 gene – a gene involved in keeping insulin-producing cells in the pancreas working properly.

27 April 2018

We have committed to invest £2.6 million in 19 brand new projects which aim to make life-changing improvements in diabetes care, and reduce people’s risk of Type 2 diabetes. 

The funding will be given to projects looking into Type 1, Type 2 and gestational diabetes. In one of these projects, Dr Freya Harrison, from the University of Warwick, will be using medieval remedies to find new sources of antibiotics.

02 March 2018

Type 2 diabetes could be broken down into different subtypes, according to research published today in the Lancet Diabetes and Endocrinology.

Scientists in Sweden and Finland have found that Type 2 diabetes could be separated out into four subtypes, which have distinct characteristics. This suggests that people with Type 2 diabetes might be affected by their diabetes in different ways and benefit from different treatments.

26 January 2018

A study of older people in the UK suggests people with diabetes lose cognitive ability faster than people with normal blood sugar control.  

The findings, published today in Diabetologia, was led by researchers at Imperial College London. They studied more than 5,000 people over the age of 50 and measured their cognitive decline over a 10 year period.